Anti-VEGFR Vaccine Therapy in Treating Patients With Neovascular Maculopathy

Clinical trial NCT00791570 · COMPLETED

Trial details

NCT number: NCT00791570
Sponsor: Osaka University
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neovascular Maculopathy Age Related Macular Degeneration

Start date: 2008-10-01
Primary completion: 2012-04-01
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.